Not Signed In -
Breathing meditation |
|
|
Clinical Trial: Meditation-Based Stress Reduction in Rheumatoid Arthritis
This study has been completed.
|
Purpose
The purpose of this study is to determine whether a mindfulness meditation-based stress reduction program is useful in relieving symptoms associated with rheumatoid arthritis (RA).
| Condition | Treatment or Intervention | Phase |
|---|---|---|
| Rheumatoid Arthritis | Behavior: stress reduction program Behavior: meditation | Phase II |
MedlinePlus related topics: Rheumatoid Arthritis
Study Type: Interventional
Study Design: Educational/Counseling/Training, Randomized, Open Label, Active Control, Single Group Assignment, Efficacy Study
Official Title: Mindfulness Meditation-Based Stress Reduction in Relieving Symptoms Associated with Rheumatoid Arthritis
Expected Total Enrollment: 80
Study start: July 2003; Study completion: March 2005
Eligibility
Ages Eligible for Study: 18 Years and above, Genders Eligible for Study: Both
Criteria
Inclusion criteria:
- Confirmed diagnosis of RA, with doctor's letter or doctors' bill with ICD code 714;
- 18 years of age or older;
- Able to read and write English;
- Able to attend 15 course sessions and questionnaire sessions at Kernan Hospital in Baltimore;
- Willing to practice skills for 45 minutes to 1 hour per day, 6 days a week;
- Stable on rheumatoid medications for at least one month.
Exclusion criteria:
- Major psychiatric illness (bipolar disorder, multiple personality disorder, etc.);
- Active alcoholism or drug dependency;
- Scheduled for major surgery during the study period;
- Enrolled in randomized clinical trial for rheumatoid arthritis during the study period;
- Planning to move out of the area in the next 12 months;
- Unwilling to be enrolled in a control group;
- Use of assistive device other than a cane;
- Serious health condition(s) that the investigator determines would make it difficult to complete the 6 month study;
- Diagnosis of fibromyalgia.
Location Information
Maryland
University of Maryland School of Medicine - Kernan Hospital, Baltimore, Maryland, 21207, United States
Brian Berman, MD, Principal Investigator, Director, Center for Integrative Medicine
More Information
http://www.compmed.umm.edu
Publications
Kabat-Zinn J. An outpatient program in behavioral medicine for chronic pain patients based on the practice of mindfulness meditation: theoretical considerations and preliminary results. Gen Hosp Psychiatry. 1982 Apr;4(1):33-47.
Kabat-Zinn J, Lipworth L, Burney R. The clinical use of mindfulness meditation for the self-regulation of chronic pain. J Behav Med. 1985 Jun;8(2):163-90.
Kabat-Zinn J, Massion AO, Kristeller J, Peterson LG, Fletcher KE, Pbert L, Lenderking WR, Santorelli SF. Effectiveness of a meditation-based stress reduction program in the treatment of anxiety disorders. Am J Psychiatry. 1992 Jul;149(7):936-43.
Miller JJ, Fletcher K, Kabat-Zinn J. Three-year follow-up and clinical implications of a mindfulness meditation-based stress reduction intervention in the treatment of anxiety disorders. Gen Hosp Psychiatry. 1995 May;17(3):192-200.
Kaplan KH, Goldenberg DL, Galvin-Nadeau M. The impact of a meditation-based stress reduction program on fibromyalgia. Gen Hosp Psychiatry. 1993 Sep;15(5):284-9.
Record last reviewed: March 2005
Last Updated: March 2, 2005
Record first received: October 17, 2003
ClinicalTrials.gov Identifier: NCT00071292
Health Authority: United States: Federal Government
ClinicalTrials.gov processed this record on 2005-04-08
Source: ClinicalTrials.gov
Cache Date: April 9, 2005
email this page
print this page
bookmark this page
feedback on this page
